/MLGML.PA

MLGML.PA Stock - Gour Medical S.A.

Q: What is the analyst price target for MLGML.PA?

Analyst price target information is not currently available for MLGML.PA.

Q: What is MLGML.PA's market cap?

Market capitalization information is not currently available for MLGML.PA.

Healthcare|Drug Manufacturers - Specialty & Generic|PAR

$0.04-20.00%

$0.01 (-20.00%) • Jun 30

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

100

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $0.04

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for MLGML.PA

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2018

FY2019

FY2020

FY2021

FY2022

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta-0.24

52W High$0.06

52W Low$0.02

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2022	FY2021	FY2020	FY2019	FY2018
Revenue	$1.08	$870.65	$4,073.49	$6,091.62	$1,539.94
Gross Profit	$1.08	$-12,239.35	$-91,542.51	$-195,958.38	$-130,606.06
Gross Margin	100.0%	-1405.8%	-2247.3%	-3216.9%	-8481.2%
Operating Income	$-56,145.8	$-143,090.76	$-122,070.31	$-213,456.58	$-130,853.44
Net Income	$-79,542.46	$-191,511.3	$-122,909.17	$-215,357.6	$-146,612.26
Net Margin	-7365042.6%	-21996.4%	-3017.3%	-3535.3%	-9520.6%
EPS	$-0.02	$-0.06	$-0.04	$-0.06	$-0.05

Company Overview

Gour Medical SA engages in the development and marketing of various veterinary solutions for companion animals. It provides cannabidiol-based solutions for pets under the WEEDLEY brand. The company was founded in 2014 and is based in Paris, France.

Visit Website

Frequently Asked Questions about MLGML.PA

What is MLGML.PA's current stock price?

Gour Medical S.A. (MLGML.PA) is currently trading at $0.04 per share. The stock has moved -20.00% today.

What is the analyst price target for MLGML.PA?

No analyst price targets are currently available for this stock.

What sector is Gour Medical S.A. in?

Gour Medical S.A. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. The company is traded on the PAR exchange.

What is MLGML.PA's market cap?

Gour Medical S.A. has a market capitalization of $0.00 billion, making it a small-cap company.

Does MLGML.PA pay dividends?

No, Gour Medical S.A. does not currently pay a dividend to shareholders.